Article Versions Notes

Tudor DV, Florea A, Cenariu M, Olteanu DE, Farcaș M, Hopârtean A, Clichici SV, Filip GA. Low Doses of Celecoxib Might Promote Phenotype Switching in Cutaneous Melanoma Treated with Dabrafenib—Preliminary Study. Journal of Clinical Medicine. 2022; 11(15):4560. https://doi.org/10.3390/jcm11154560

Tudor, Diana Valentina, Adrian Florea, Mihai Cenariu, Diana Elena Olteanu, Marius Farcaș, Andreea Hopârtean, Simona Valeria Clichici, and Gabriela Adriana Filip. 2022. "Low Doses of Celecoxib Might Promote Phenotype Switching in Cutaneous Melanoma Treated with Dabrafenib—Preliminary Study" Journal of Clinical Medicine 11, no. 15: 4560. https://doi.org/10.3390/jcm11154560

Tudor, D. V., Florea, A., Cenariu, M., Olteanu, D. E., Farcaș, M., Hopârtean, A., Clichici, S. V., & Filip, G. A. (2022). Low Doses of Celecoxib Might Promote Phenotype Switching in Cutaneous Melanoma Treated with Dabrafenib—Preliminary Study. Journal of Clinical Medicine, 11(15), 4560. https://doi.org/10.3390/jcm11154560